市場調查報告書
商品編碼
1370224
臨床試驗用品市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球臨床試驗用品市場規模達到23億美元。展望未來,IMARC Group預計到2028年該市場將達到36億美元,2023-2028年年複合成長率(CAGR)為7.4%。
臨床試驗用品是指用於進行科學實驗、調查和臨床研究的各種工具和設備。輸液幫浦、霧化器和注射器針頭是最常用的臨床試驗用品。它們主要用於進行檢測、預防和治療各種疾病的醫學試驗,分析治療方法的效率,以及診斷各種感染性和代謝性疾病。它們在呼吸、腫瘤、心血管和神經手術中也被廣泛應用。
生物製藥產業的顯著成長是推動市場成長的關鍵因素之一。隨著創新藥物輸送系統的發展,臨床試驗在治療愛滋病毒和癌症等疾病方面獲得了巨大的吸引力。此外,促進冷鏈物流和監控技術發展的技術進步也是關鍵的成長誘導因素。產品製造商專注於最佳化生產和包裝流程,以最大限度地減少浪費並提高整體成本效率。此外,合約研究組織(CRO)的新興趨勢也對市場成長產生正面影響。 CRO 使製藥、生物技術和醫療器材製造商能夠以合約形式外包研究活動,從而提高各種試驗用品的利用率。其他因素,包括政府和非政府組織(NGO)為開發先進藥物和治療方法而進行的廣泛研究和開發(R&D),預計將為市場創造積極的前景。
The global clinical trial supplies market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.
Clinical trial supplies refer to various tools and equipment that are used for conducting scientific experiments, investigations and clinical research. Infusion pumps, nebulizers and syringe needles are the most commonly used clinical trial supplies. They are primarily used for conducting medical trials for detecting, preventing and treating various ailments, analyzing the efficiency of a treatment method, and in the diagnosis of various infectious and metabolic disorders. They also find extensive applications during respiratory, oncological, cardiovascular and neurological procedures.
Significant growth in the biopharmaceutical industry is one of the key factors driving the growth of the market. Clinical trials are gaining immense traction for treating diseases, such as HIV and cancer, along with the development of innovative drug delivery systems. Furthermore, technological advancements facilitating the development of cold chain logistics and monitoring technologies, are also acting as crucial growth-inducing factors. Product manufacturers are focusing on optimizing the production and packaging processes that can minimize wastage and enhance the overall cost-efficiency. Moreover, the emerging trend of contract research organizations (CROs) is also impacting the market growth positively. CROs enable the pharmaceutical, biotechnological and medical instrument manufacturers to outsource research activities on a contractual basis, thereby increasing the utilization of various trial supplies. Other factors, including extensive research and development (R&D) undertaken by both the governmental and non-governmental organizations (NGOs) for the development of advanced drugs and treatment methods, are expected to create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical trial supplies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on services, phase, therapeutic area, and end-use industry.
Product Manufacturing
Packaging, Labeling and Storage
Logistics and Distribution
Based on the services, the market has been segmented into product manufacturing; packaging, labeling and storage; and logistics and distribution.
Phase I
Phase II
Phase III
Others
On the basis of the phase, the market has been segregated into phase I, phase II, phase III and others. At present, phase III exhibits a clear dominance in the market.
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Others
The market has been analyzed on the basis of the therapeutic area into oncology, cardiovascular diseases, respiratory diseases, central nervous system (CNS) and mental disorders, and others. Amongst these, oncology holds the largest market share.
Medical Device Industry
Biopharmaceuticals Industry
Pharmaceuticals Industry
Others
Based on the end-use industry, the market has been divided into medical devices, biopharmaceuticals, pharmaceuticals and others. Pharmaceuticals account for the majority of the total market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
On the geographical front, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others); Latin America (Brazil, Mexico and others); and Middle East and Africa. Currently, North America enjoys the leading position in the market.
The report has also analysed the competitive landscape of the market with some of the key players being Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair, Movianto, etc.